ZEISS United Kingdom provides a range of products and solutions in areas such as vision care, medical technology, semiconductor manufacturing technology, industrial quality solutions, and microscopy. ZEISS is involved in both consumer optics and digital solutions, as self-described.

ZEISS United Kingdom

Medical Equipment Manufacturing

ZEISS Medical Technology

ZEISS Vision

Machinery Manufacturing

ZEISS Industrial Quality Solutions

Nanotechnology Research

ZEISS Microscopy

Semiconductor Manufacturing

ZEISS Semiconductor Manufacturing Technology

Movies and Sound Recording

ZEISS Cinematography

Venture Capital and Private Equity Principals

ZEISS Ventures

ZEISS Group | 369,763 followers on LinkedIn. We are a global technology leader advancing the world of optics. #SeeingBeyond | ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality &amp; Research, Medical Technology and Consumer Markets (status: 30 September 2023).

With around 43,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2023).

Head of Marketing, Go-To-Market ZEISS Vision Care US

Matt Woelbern

Driving Design Thinking & Brand Shaping UI/UX at Carl Zeiss

Niels Clausen-Stuck

James Polcyn

Managing Director ZEISS Benelux | MBA

Pascal Slot

ZEISS Group

Researching potential treatments for rare diseases: that’s all part of a day’s work for Prof. Benjamin L. Prosser from the Penn Medicine, University of Pennsylvania Health System . Recently, much of his research has centered on STXBP1 and SYNGAP1, two genes critical for neuronal communication. Mutations in these genes can disrupt essential brain functions like learning, memory and motor skills. In our interview, Prof. Prosser shares his personal journey and what drives him and his team to work on developing therapies that could correct certain genetic disorders, offering hope for medical conditions that still have no cure. #BeyondTalk ZEISS Microscopy #ZEISS #Health #Innovation

Sustainable e-mobility needs top-notch quality assurance. 🌍🚗 Ensuring the reliability and low emissions of New Energy Vehicles ( #NEV ) starts with stringent quality checks on components like batteries. That’s why ZEISS Industrial Quality Solutions is key. 📏✅ “When solving problems for the manufacturers, we prioritize safety to enhance battery quality. This results in better, longer-lasting, and more sustainable batteries,” says Yuqing, Senior Applications Engineer at ZEISS Shanghai. #ZEISS #Mobility #Innovation #Battery #QualityAssurance

What’s it like to do cutting-edge research that could impact your own family? 👨👩👧 Prof. Benjamin L. Prosser from the Penn Medicine, University of Pennsylvania Health System , shares his experiences as a #researcher and #father . A few years ago, the birth of his daughter caused him to expand his field from the mechanobiology of the heart to include rare neurodevelopmental disorders. 🧠 #ZEISS #Health #Innovation

More than 500 million adults worldwide have #diabetes . 🌍 Did you know that forms of diabetic eye disease can also lead to loss of vision? That’s where innovative solutions from ZEISS Medical Technology can help such as high-resolution fundus cameras for ultra-wide-field imaging. CLARUS fundus imaging helps doctors examine the retina and detect diseases such as diabetic retinopathy at an early stage. The risk of loss of vision can be reduced enormously if detected early and followed up by prompt treatment. On #WorldDiabetesDay , ZEISS is raising awareness about the importance of regular eye screenings and their role in detecting diabetic eye disease. Learn more about ZEISS solutions for the management of diabetic eye disease here: https://lnkd.in/d4TRD5RD #ZEISS #Innovation #Health

Did you know that your heart will beat over two billion times in your lifetime? To withstand this high-stress environment, the cells in your heart have to be strong. But genetic mutations can weaken the cardiac cells and impair the heart’s performance. Prof. Benjamin L. Prosser and his team at the Penn Medicine, University of Pennsylvania Health System are researching the heart on a molecular level to better understand the root cause of diseases like laminopathy. Learn more about how his personal story brought him to cardiac and gene research. Learn more: zeiss.com/prosser #ZEISS #BeyondTalk #Innovation

Meet Prof. Benjamin L. Prosser from the Penn Medicine, University of Pennsylvania Health System . He and his team study #cardiac diseases and rare #neurodevelopmental disorders. Discover how Prof. Prosser’s personal story has shaped his unique career path and motivates him to work on treatments for diseases that have existed throughout human history: zeiss.com/prosser 🔬 Media Courtesy Prosser Lab / Center for Epilepsy and NeuroDevelopmental Disorders #ZEISS #BeyondTalk #Innovation

What fuels scientific breakthroughs? On #WorldScienceDay , Fanny Seus , Head of Research & Innovation at the ZEISS Innovation Hub in Dresden, Germany, reminds us that it’s fresh perspectives that push the boundaries of discovery. 🔬 At ZEISS, we believe diversity sparks the creativity needed to unlock bold innovations and transform industries. 🌍 Let’s celebrate science’s power to shape a better, more sustainable future. #ZEISS #Innovation #DiversityInScience

#Throwback Did you know that ZEISS binoculars made literary history? 📓 Ernest Hemingway, winner of the Nobel Prize for Literature in 1954, actually owned several pairs of ZEISS binoculars. This came across in his writing and consequently ZEISS binoculars became part of literary history. For over 100 years, ZEISS has been manufacturing outstanding binoculars and enabling people from all over the world to discover their surroundings. #ZEISS #TB #History

Did you know that spectrometer systems from ZEISS Spectroscopy optimise the taste of #crisps ? 🌽🥔 Variations in fat, moisture and starch content, as well as seasoning, can affect the quality of crisps. Precise measurements with spectroscopy solutions from ZEISS can be used to analyse and control ingredients to get the best out of the raw materials. #ZEISS #Innovation #QualityControl

Imagine megacities like #Shanghai , where millions are constantly on the move. 🏙️👥 With the city's rapid expansion, finding sustainable ways to get around is more important than ever. E-mobility stands to transform urban transportation, but it all depends on reliable, high-performance batteries. ⚡🚗 This is where our ZEISS Industrial Quality Solutions team in Shanghai steps in, ensuring that every #battery meets rigorous standards. #ZEISS #Mobility #emobility #Innovation

Domain Not Resolving

HSTS

Google Font API

DNSSEC

Amazon

Font Awesome

nginx

reCAPTCHA

Cloudflare CDN

IPv6

Chief Engineer

Canh Nguyen

President and CEO | North America

Kenny Patterson

Member of the Executive Board of the ZEISS Group and President and CEO of Carl Zeiss SMT GmbH

Markus Weber

President

Moosah Gulam

Business Service Owner - Contact Centre Solutions

Simon Oakes

Vice President Marketing

Andrew Hyncik

Vice President / General Manager, Latin America

David Ferran

Vice President, Head of Marketing and Customer Experience, North America

Joseph Huff

Vice President, Semiconductor Manufacturing Technology, SBU PCS

Manfred Hanke

S.V.P., Head of US Retail

Steve Mitrakos

Michael Kaschke

Nityanand Rai

Digital Marketing Manager, APAC

President and CEO

Norbert Gergely

Head of Enterprise Data Management

R. Michael Crompton

Vice President, Regulatory/Clinical Affairs & Quality Assurance

Carl Zeiss

Founder

Parastou Navabi

Working student Human Resources

Nils Noack

Digital Partnership Manager

Jörg Marzel

Global CISO

Germany Companies (Top 10K)

Germany Companies With More Than $500 in Revenue

European Union (EU) Companies With More Than 100 Employees (Top 10K)

Germany Companies With More Than $100M in Revenue

Zeiss is a manufacturer of optical systems, industrial measurements, and medical devices. The company develops optical systems such as lithography systems, industrial measuring technology, microscopes, surgical microscopes, ophthalmic diagnostic and therapy systems, eyeglass lenses, planetarium technology, and cine and camera lenses as well as binoculars, riflescopes, and spotting scopes.

Zeiss provides microchips; measuring solutions that are used to make various components such as micro and macro parts, ship engines, and wind turbines; microscope systems for biomedical research and materials inspection; medical systems that are used in ophthalmology, and neurosurgery as well as ear, nose, and throat surgery; and consumer optics such as camera lenses, sports optics, planetariums, and cinemizers.

Computer and Software Products and Electrical and Scientific Products

Oberkochen

Baden-Wurttemberg

Germany

Europe

Samsung Boosts Chip Production Capabilities through Partnership with ZEISS Group

ZEISS and University of Oxford Collaborate to Advance Biomedical Imaging

Zeiss Group to invest Rs 2,500 cr on new plant in India

Another very successful year for the ZEISS Group

ZEISS and EOS partner over powder bed monitoring system for 3D printing

Eyeglass lens producer opens headquarters in Kentucky

ZEISS provides equipment for semiconductor manufacturing, supporting the production of microchips and contributing to global digitalization.

ZEISS offers medical devices and solutions for ophthalmology and microsurgery, enhancing medical procedures and patient care.

ZEISS delivers measurement technology for industrial applications, ensuring precision and quality in manufacturing processes.

ZEISS produces optical, electron/ion, and X-ray microscopes for visualizing micro- and nanostructures in research.

ZEISS manufactures lenses for photography and filmmaking, used by professionals to capture high-quality images and films.

ZEISS provides riflescopes and thermal imaging devices for hunting, aiding in accurate targeting.

news impact assignment basic	general
public peers	general	Nov 23, 2024 12:50 PM	754cd73d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 23, 2024 12:50 PM	374d0454
crunchbase trigger	general	Nov 23, 2024 12:50 PM	14d33846
crunchbase profile	general	Nov 24, 2024 5:33 AM	3df9652d
li profile	general	Nov 23, 2024 12:50 PM	04549f73
translate crunchbase fundingrounds	general	Nov 24, 2024 6:10 AM	52e5af30
peers	general	Nov 23, 2024 12:50 PM	8a238cdb
news basic	general	Nov 23, 2024 12:50 PM	8e37002b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CO

UK:CO:ZEISS

ZEISS United Kingdom